GEORGE VAN BUREN to Cell Line, Tumor
This is a "connection" page, showing publications GEORGE VAN BUREN has written about Cell Line, Tumor.
Connection Strength
0.205
-
Targeting the urokinase plasminogen activator receptor with a monoclonal antibody impairs the growth of human colorectal cancer in the liver. Cancer. 2009 Jul 15; 115(14):3360-8.
Score: 0.049
-
The development and characterization of a human midgut carcinoid cell line. Clin Cancer Res. 2007 Aug 15; 13(16):4704-12.
Score: 0.043
-
Mutant p53R175H promotes cancer initiation in the pancreas by stabilizing HSP70. Cancer Lett. 2019 07 01; 453:122-130.
Score: 0.024
-
SRC-3 inhibition blocks tumor growth of pancreatic ductal adenocarcinoma. Cancer Lett. 2019 02 01; 442:310-319.
Score: 0.023
-
Overexpression of Semaphorin-3E enhances pancreatic cancer cell growth and associates with poor patient survival. Oncotarget. 2016 Dec 27; 7(52):87431-87448.
Score: 0.021
-
Neuropilin-2-mediated tumor growth and angiogenesis in pancreatic adenocarcinoma. Clin Cancer Res. 2008 Dec 15; 14(24):8052-60.
Score: 0.012
-
Therapeutic targeting of Id2 reduces growth of human colorectal carcinoma in the murine liver. Oncogene. 2008 Dec 04; 27(57):7192-200.
Score: 0.012
-
Effect of chemotherapeutic stress on induction of vascular endothelial growth factor family members and receptors in human colorectal cancer cells. Mol Cancer Ther. 2008 Sep; 7(9):3064-70.
Score: 0.012
-
Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines. Clin Cancer Res. 2006 Jul 15; 12(14 Pt 1):4147-53.
Score: 0.010